Chinese Herb for the Treatment of Depression and Anxiety Disorders
Status:
Unknown status
Trial end date:
2018-12-30
Target enrollment:
Participant gender:
Summary
Anxiety and depression are currently among the ten most important public health concerns, and
in recent years, have reached epidemic proportions. Anxiety is recognized as the main risk
factor for many diseases including cardiovascular, metabolic and neuropsychiatric disorders.
Current anxiolytic medications have a relatively low success rate (~50%) and are associated
with many deleterious side-effects. The investigators aim to investigate the efficacy,
safety, and tolerability of a novel herbal treatment on anxiety and depression symptoms in a
6-week double-blind randomized trial.